Table 3.
Clinical features of patients during acute COVID-19 infection by cluster.
| Clinical feature during COVID-19 | Cluster 1. Multisystem + lab | Cluster 2. Pulmonary | Cluster 3. Neuropsychiatric | Cluster 4. Cardiopulmonary | Cluster 5. Pain/fatigue | Cluster 6. Multisystem-pain |
|---|---|---|---|---|---|---|
| Acute kidney injury | 14.5% a | 6.3% b | 4.2% b | 4.4% b | 4.8% b | 4.1% b |
| Corticosteroid regimen | 30.2% a | 19.8% b | 14.1% b | 14.4% b | 15.4% b | 13.8% b |
| COVID diagnosis during hospitalisation | 34.0% a | 21.0% b | 16.2% b | 15.2% b | 17.6% b | 15.8% b |
The 3 of 43 clinical features present during COVID-19 infection (Supplemental Table S13) that were significantly overrepresented in clusters (chi squared p < 0.001 after Bonferonni correction) and the percent of patients in each cluster with each clinical feature are shown. Letters a and b indicate CLD groups between which differences for the given clinical feature are statistically significant according to post hoc analysis (Methods).